Indication:
Mixed anxiety and depression
Panic Disorders
Bulmia Nervosa
Obessive compulsive disorder
Premenstrual dysphoric disorder
Drug Interaction:
Seen with monoamine oxidase inhibitors (MAO)
Oral anticogulants
Anti-convulsants
Some Antifungals such as Ketoconazole and Itraconazole
Adverse Reaction:
Nervousness, anxiety, seizures, blurred vision,
Jaundice, GI disturbances, Vertigo,
Headache, elevation of hepaic enzymes
Contra-Indications:
Severe renal or hepatic failure
Hypersensitivity
Pregnancy
Lactation
Respiratory depression
Acute Narrow Angle Glaucoma
Pharmacology/ Pharmacokinetics:
Pharmcology-
Fluoxetine
Fluoxetine HCl is an antidepressant of selective serotonin reuptake inhibitor ( SSRI) class.
It inhibits central reuptake system ( CNS) neutronal uptake os serotin into human platelets.
Alprozolam
Alprazolam a triazolobenzadiazepine is a benzodiazepine with a triazolo- ring attached to its structure.
Pharmacokinetics-
Fluoxetine is slowly absorbed from the GIT with the peak with the peak plasma concentration occuring about 6-8 hrs
after ingestion. It is extensively metabolised in the liver to nor-fluoxetine by de-methylation pathway.It is widely
distributed in the body and is highly bound to plasma proteins, with a half life of 4-6 days.
Alaprazolam is readily absorbed from the GI tract with a bioavailabilty of 80-90 %
Peak Plasma concentration is acheived in 1-2 hrs.
Rapidly absorbed triughout the body and bound to plasma proteins.
Elimination half life is 10-11 hours.
Dosages/ Overdosage Etc:
Mixed anxiety and depression
Panic Disorders
Bulmia Nervosa
Obessive compulsive disorder
Premenstrual dysphoric disorder
20-40mg daily
Max 80mg daily